NMPA Approval

Sitagliptin Phosphate and Metformin Hydrochloride Sustained-release Tablets

Approval Number

国药准字H20213961

Company南京正大天晴制药有限公司

Registration Date

December 31, 2021

Drug Information

Generic Name

西格列汀二甲双胍缓释片

Dosage Form

片剂

Strength

每片含磷酸西格列汀100mg（按C16H15F6N5O计）和盐酸二甲双胍1000mg

Drug Type

化学药品

Registration Date

December 31, 2021

Company Information

Applicant Company

Company Name南京正大天晴制药有限公司

Company Address

南京经济技术开发区惠欧路9号

Manufacturing Company

Company Name南京正大天晴制药有限公司

Company Address

南京经济技术开发区惠欧路9号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

西格列汀二甲双胍缓释片 - NMPA 批准文号 | MedPath